Circadian Health Innovations in Medicine, Epidemiology & Sleep (CHIMES) Symposium
The Circadian Health Innovations in Medicine, Sleep & Epidemiology Symposium (CHIMES), hosted by the Aging Initiative, aims to highlight innovation in wearable technology, AI/ML unlocking sleep physiology, and groundbreaking first-in-class therapeutics. Special thanks to Ultrahuman for their generous support. Note: registration approval is required to attend!
We are pleased to announce Richard Pops, Chair of Alkermes ($7.7B+ public biotech) and head of the Midsized Biotech Alliance of America (MBAA) and former chair of the Biotechnology Innovation Organization (BIO) & Pharmaceutical Research and Manufacturers of America (PhRMA), as our opening speaker.
Ed Baker, Chief Product Officer of WHOOP, will be joining us as closing speaker. Previously, he served as the VP of Product and Growth at Uber and the Head of International Growth at Facebook. An elite endurance athlete and triathlete himself, his work sits at the exact intersection of scaling wearables and human performance.
Our tentative schedule for CHIMES is outlined below:
2:40 - 2:55 pm: Guest Arrival
3:00 - 3:05 pm: Opening Remarks by Aging Initiative Team
3:05 - 3:15 pm: Flash Talk by Dr. Pavan Kumar (GM, Ultrahuman)
3: 15- 3:50 pm: Fireside Chat with Richard Pops (Chairman & Former CEO, Alkermes)
3:50 - 4:30 pm: Unlocking Sleep with Big Data and AI
Dr. Jay Pathmanathan, Medical Director, Beacon Biosignals
Dr. Elizabeth Klerman, Professor of Neurology, MGH/HMS
Dr. Olivia Walch, CEO & Co-Founder, Arcascope
Dr. Pavan Kumar, General Manager, Ultrahuman
4:35 - 5:20 pm: Next Generation Sleep Therapeutics
Dr. Luigi Taranto Montemurro, Chief Scientific Officer, Apnimed
Dr. Paul Dagum, CEO & Co-Founder, Applied Cognition.
Mike Masterson, Partner & Co-Founder, Supermoon Capital
5:25 - 6:20 pm: Refreshments and Poster Session
6:25 - 6: 55 pm: Fireside Chat with Ed Baker (CPO, WHOOP)
6:55 - 7:00 pm: Closing remarks
Sleep and circadian disruption represent some of the largest yet most underaddressed contributors to pathology today, including neurodegenerative decline and cardiometabolic disorders. For decades, clinical practice has relied on symptom management and cumbersome devices. Today, the convergence of advances in large scale data analysis, sensor modalities, and targeted therapies makes it possible to better understand and address mechanisms of disease directly. We bring together founders, researchers, clinicians, biopharma executives, investors, and students to catalyze discussion surrounding the future of sleep and human health.
About the Aging Initiative:
The Aging Initiative is a 501c3 nonprofit organization based in Boston. We actively build community across the New England aging research ecosystem.
If you would like to sponsor the CHIMES Symposium, please contact us at info@aging-initiative.org.